These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 10785478

  • 1. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
    Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W.
    Gynecol Oncol; 2000 May; 77(2):278-82. PubMed ID: 10785478
    [Abstract] [Full Text] [Related]

  • 2. Quantification of p53 in epithelial ovarian cancer.
    Geisler JP, Geisler HE, Wiemann MC, Givens SS, Zhou Z, Miller GA.
    Gynecol Oncol; 1997 Sep; 66(3):435-8. PubMed ID: 9299258
    [Abstract] [Full Text] [Related]

  • 3. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [Abstract] [Full Text] [Related]

  • 4. p53 expression as a prognostic indicator of 5-year survival in endometrial cancer.
    Geisler JP, Geisler HE, Wiemann MC, Zhou Z, Miller GA, Crabtree W.
    Gynecol Oncol; 1999 Sep; 74(3):468-71. PubMed ID: 10479512
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G, Wittmann A, Dammrich J, Bassukas ID.
    Anticancer Res; 1996 Sep; 16(6B):3807-11. PubMed ID: 9042262
    [Abstract] [Full Text] [Related]

  • 7. Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma.
    Geisler JP, Geisler HE, Tammela J, Wiemann MC, Zhou Z, Miller GA, Crabtree W.
    Gynecol Oncol; 1998 Apr; 69(1):14-6. PubMed ID: 9570992
    [Abstract] [Full Text] [Related]

  • 8. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma.
    Kahlenberg MS, Stoler DL, Rodriguez-Bigas MA, Weber TK, Driscoll DL, Anderson GR, Petrelli NJ.
    Cancer; 2000 Apr 15; 88(8):1814-9. PubMed ID: 10760757
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 12; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jan 12; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
    de la Torre FJ, García A, Gil-Moreno A, Planaguma J, Reventos J, Ramón y Cajal S, Xercavins J.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan 12; 130(1):121-8. PubMed ID: 16876311
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
    Georgiou A, Gomatos IP, Ferekidis E, Syrigos K, Bistola V, Giotakis J, Adamopoulos G, Androulakis G.
    Eur J Surg Oncol; 2001 Sep 12; 27(6):574-80. PubMed ID: 11520092
    [Abstract] [Full Text] [Related]

  • 14. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
    Casper F, Weikel W, Schaffrath M, Kuner RP, Hoffmann G, Pollow B, Pollow K.
    Zentralbl Gynakol; 2000 Sep 12; 122(3):153-9. PubMed ID: 10756599
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 12; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 16. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM, van der Wurff AA, van de Water M, Kruitwagen RF, Feijen HW, Vos MC.
    Int J Gynecol Pathol; 2009 Sep 12; 28(5):432-41. PubMed ID: 19696612
    [Abstract] [Full Text] [Related]

  • 17. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S, Chapman W, McLaughlin J, Andrulis IL.
    Cancer J; 2000 Sep 12; 6(5):302-8. PubMed ID: 11079169
    [Abstract] [Full Text] [Related]

  • 18. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD, Munkarah AR.
    Cancer; 2003 Oct 01; 98(7):1423-9. PubMed ID: 14508829
    [Abstract] [Full Text] [Related]

  • 19. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A, Bezerra AL, Pinto CA, Serrano SV, de MellO CA, Villa LL.
    J Urol; 2002 Jul 01; 168(1):81-6. PubMed ID: 12050497
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
    Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC, Mills GB, Silva EG.
    Clin Cancer Res; 1999 Dec 01; 5(12):4053-8. PubMed ID: 10632339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.